Driving Purpose-Driven Innovations to Enable Business Growth, Competitive Advantage, and Shareholder Value"As a senior executive in the healthcare industry, I lead growth through purpose-driven innovation, optimizing revenues, and increasing profitability. My leadership is focused on strategic change, continuous improvement, talent development, and product/service optimization to deliver sustainable results.With extensive experience in U.S. along with global R&D and Clinical Affairs, I have successfully led turnaround efforts, managed M&A integrations, and worked across diverse healthcare sectors—including medical devices, diagnostics, software, and services. My work spans multiple medical specialties and settings, including radiology, surgery, radiation oncology and medication delivery solutions. This has resulted in the development and launch of innovative platforms and breakthrough technologies that have strategically advanced the healthcare continuum, impacting global patient care. I am known for my ability to analyze strategic innovation opportunities, lead organizational transformation, and build high-performing teams that drive market leadership and enhance corporate value. As a financially astute business leader, I leverage these skills to create value, strengthen business operations, and ensure that both growth and talent development are aligned with long-term business objectives.Notable Achievements:Business & Revenue Growth: Drove new concept, product, and business development initiatives that resulted in year-over-year (YoY) revenue growth at Hologic (BSH BU) and Becton Dickinson (MDS BU), increasing growth from under 1% to a sustainable 5+%.New Products Platform Development: Led the development of nine strategic product platforms at Hologic and three at BD, now accounting for 90% of Hologic’s division revenue and 60% of new product development (NPD) revenue at BD.Technology Innovations: Spearheaded groundbreaking technologies such as Genius™ 3D Tomosynthesis and Genius™ AI Detection, which improved invasive breast cancer detection by 41% and reduced recall rates by 40%. These innovations earned multiple accolades. Currently leading two breakthrough solutions at BD, projected to generate $140 million in incremental revenue by FY27.Global R&D and Clinical Affairs Leadership: Championed the implementation of Purpose & Insights-Driven Innovation (IDI) processes, Jobs-to-be-Done (JTBD) customer-centric design thinking. These efforts resulted in double-digit growth in new initiatives at both BD and Hologic.